MarketCapTrends
ANGO
Angiodynamics Inc. (ANGO)
NASDAQ · Healthcare

Angiodynamics Inc. Shareholder Equity 2010–2025

Angiodynamics Inc. annual/quarterly shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Angiodynamics Inc. shareholder equity for the quarter ending May 31, 2025 were 183.0M, a 11.00% decrease year-over-year.
  • Angiodynamics Inc. shareholder equity for 2025 were 183.0M, a 11.00% decrease from 2024.
  • Angiodynamics Inc. shareholder equity for 2024 were 205.6M, a 45.65% decrease from 2023.
  • Angiodynamics Inc. shareholder equity for 2023 were 378.3M, a 10.88% decrease from 2022.
  • Angiodynamics Inc. shareholder equity for 2022 were 424.5M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Angiodynamics Inc. Annual Shareholder Equity (Millions of US $)
2025$183
2024$206
2023$378
2022$424
2021$439
2020$455
2019$615
2018$543
2017$515
2016$507
2015$545
2014$537
2013$526
2012$523
2011$406
Angiodynamics Inc. Quarterly Shareholder Equity (Millions of US $)
2025-05-31$183
2024-05-31$206
2023-05-31$378
2022-05-31$424
2021-05-31$439
2020-05-31$455
2019-05-31$615
2018-05-31$543
2017-05-31$515
2016-05-31$507
2015-05-31$545
2014-05-31$537
2013-05-31$526
2012-05-31$523
2011-05-31$406

Angiodynamics Inc. Shareholder Equity — FAQ

Angiodynamics Inc. (ANGO) shareholder equity over the last 16 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ANGO's shareholder equity history?

The chart and table above show Angiodynamics Inc.'s shareholder equity by year and by quarter, including the growth rate.